Amyris, Inc. (AMRS)
| Market Cap | 3.53B |
| Revenue (ttm) | 320.87M |
| Net Income (ttm) | -585.80M |
| Shares Out | 267.73M |
| EPS (ttm) | -2.53 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 10 |
| Last Price | $11.49 |
| Previous Close | $12.22 |
| Change ($) | -0.73 |
| Change (%) | -5.97% |
| Day's Open | 12.09 |
| Day's Range | 11.41 - 12.25 |
| Day's Volume | 2,582,883 |
| 52-Week Range | 1.88 - 23.42 |
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -575.00% and 367.23%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
EMERYVILLE, Calif., May 6, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today an...
EMERYVILLE, Calif., May 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier o...
Amyris' (AMRS) Q1 results are likely to have benefited from continued strong growth in its consumer brands.
EMERYVILLE, Calif. and WESTCHESTER, Ill.
Amyris, Inc. (AMRS) closed at $14.56 in the latest trading session, marking a -1.42% move from the prior day.
Amyris, Inc. (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EMERYVILLE, Calif., April 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a...
EMERYVILLE, Calif., April 21, 2021 /PRNewswire/ -- Amyris, Inc., (Nasdaq: AMRS) a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a...
EMERYVILLE, Calif., April 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...
EMERYVILLE, Calif., April 14, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...
Amyris, Inc. (NASDAQ:AMRS) is a synthetic biotech and renewable chemical company.
Amyris Announces Pricing of a $300.0 Million Public Offering (Secondary and Primary) of Common Stock
EMERYVILLE, Calif., April 9, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer bra...
EMERYVILLE, Calif., April 7, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer bra...
If you check the summary page for Amyris Inc. (NASDAQ:AMRS) at GuruFocus, you'll find a lot of weak metrics. That includes ratings of 1 out of 10 for both financial strength and profitability.
A rebounding economy is a good time to thaw out your risk capital and start buying some high-risk stocks with long-term potential. The post 8 High-Risk Stocks to Buy That Are Worth Taking A Chance On ap...
EMERYVILLE, Calif., April 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...
EMERYVILLE, Calif., April 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...
EMERYVILLE, Calif., March 31, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...
EMERYVILLE, Calif., March 25, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...
TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Amazon and Microsoft
EMERYVILLE, Calif., March 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...
The market for sustainable personal care products is booming. Amyris, one of the earliest synthetic biology companies, is launching new brands to ride the wave.
Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO Josh Brown and Benzinga CEO Jason Raznick host "The Boiler Room," a Clubhouse audio chat where listeners can pitch their favorite stock.
EMERYVILLE, Calif., March 10, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...
EMERYVILLE, Calif., March 9, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...
Shares of Amyris (NASDAQ:AMRS) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 92.11% year over year to ($0.03), which beat the estimate of ($0.09).
These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for March.
Even with the market at historic highs, there are still plenty of young growth stocks that have their whole future ahead of them. The post 7 A-Rated Growth Stocks To Buy For Today And Tomorrow appeared ...
These are the marijuana stocks with the best value, fastest growth, and most momentum for February 2021.
Some of the best cheap stocks for 2021 include chipmakers like UMC stock and pharmaceuticals in the COVID-19 vaccine race such as INO stock. The post 7 Great Cheap Stocks To Buy For Solid Growth In 2021...
EMERYVILLE, Calif., Jan. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...
EMERYVILLE, Calif., Dec. 28, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a ...
Investors need to pay close attention to Amyris (AMRS) stock based on the movements in the options market lately.
Amyris (AMRS) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
EMERYVILLE, Calif., Dec. 21, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a ...
Amyris has multiple major transactions around the corner. The political and market environment favor the company greatly.
EMERYVILLE, Calif., Dec. 3, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a t...
These are the marijuana stocks with the best value, fastest growth, and most momentum for December.
These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for November.
Amyris, Inc. (AMRS) CEO John Melo on Q3 2020 Results - Earnings Call Transcript
EMERYVILLE, Calif., Oct. 30, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplie...
BENSALEM, Pa.--(BUSINESS WIRE)---- $AMRS #CLASSACTION--INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)---- $AMRS #CLASSACTION--Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
EMERYVILLE, Calif., Oct. 23, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplie...
SEATTLE, Oct. 20, 2020 /PRNewswire/ -- Arzeda, the Protein Design Company™, today announced that the company has entered into a joint development agreement with Amyris that leverages the complementary n...
About AMRS
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Ins... [Read more...]
| Industry Specialty Chemicals | IPO Date Sep 28, 2010 |
| CEO John Melo | Employees 595 |
| Stock Exchange NASDAQ | Ticker Symbol AMRS |
Financial Performance
In 2020, Amyris's revenue was $173.14 million, an increase of 13.49% compared to the previous year's $152.56 million. Losses were -$331.04 million, 36.4% more than in 2019.
Analyst Forecasts
According to 4 analysts, the average rating for Amyris stock is "Strong Buy." The 12-month stock price forecast is 26.00, which is an increase of 126.28% from the latest price.